| pubmed-article:19174400 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C0078058 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C0730285 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C1171892 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C1554888 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19174400 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:19174400 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19174400 | pubmed:dateCreated | 2009-1-28 | lld:pubmed |
| pubmed-article:19174400 | pubmed:abstractText | The aim of the study was to assess the safety and bioactivity of a single intravitreal injection of vascular endothelial growth factor (VEGF) Trap-Eye in subjects with diabetic macular oedema (DMO). | lld:pubmed |
| pubmed-article:19174400 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174400 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19174400 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174400 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19174400 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174400 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174400 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174400 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174400 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19174400 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19174400 | pubmed:issn | 1468-2079 | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:CedarbaumJ... | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:ShahS MSM | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:BrowningD JDJ | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:HallerJ AJA | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:CidEE | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:YanoCC | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:CampochiaroP... | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:NguyenQ DQD | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:IngermanAA | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:EDASS | lld:pubmed |
| pubmed-article:19174400 | pubmed:author | pubmed-author:VittiR LRL | lld:pubmed |
| pubmed-article:19174400 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19174400 | pubmed:volume | 93 | lld:pubmed |
| pubmed-article:19174400 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19174400 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19174400 | pubmed:pagination | 144-9 | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:meshHeading | pubmed-meshheading:19174400... | lld:pubmed |
| pubmed-article:19174400 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19174400 | pubmed:articleTitle | An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. | lld:pubmed |
| pubmed-article:19174400 | pubmed:affiliation | The Wilmer Eye Institute, 600 North Wolfe Street, Maumenee #719, Baltimore, MD 21287, USA. | lld:pubmed |
| pubmed-article:19174400 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19174400 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19174400 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174400 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174400 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174400 | lld:pubmed |
